rs141538143

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000268.4(NF2):​c.1451T>C​(p.Met484Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000148 in 1,614,048 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M484V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00076 ( 2 hom., cov: 32)
Exomes 𝑓: 0.000084 ( 1 hom. )

Consequence

NF2
NM_000268.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 4.48

Publications

5 publications found
Variant links:
Genes affected
NF2 (HGNC:7773): (NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor) This gene encodes a protein that is similar to some members of the ERM (ezrin, radixin, moesin) family of proteins that link cytoskeletal components with proteins in the cell membrane. The encoded protein is involved in regulation of contact-dependent inhibition of cell proliferation and functions in cell-cell adhesion and transmembrane signaling. The encoded protein has been shown to interact with cell-surface proteins, proteins involved in cytoskeletal dynamics, and proteins involved in regulating ion transport. Disruption of this protein's function has been implicated in tumorigenesis and metastasis. Mutations in this gene are associated with neurofibromatosis type II which is characterized by nervous system and skin tumors and ocular abnormalities. [provided by RefSeq, May 2022]
NF2 Gene-Disease associations (from GenCC):
  • NF2-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • familial meningioma
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010653704).
BP6
Variant 22-29678200-T-C is Benign according to our data. Variant chr22-29678200-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 134894.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000762 (116/152308) while in subpopulation AFR AF = 0.00274 (114/41562). AF 95% confidence interval is 0.00233. There are 2 homozygotes in GnomAd4. There are 54 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 116 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000268.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF2
NM_000268.4
MANE Select
c.1451T>Cp.Met484Thr
missense
Exon 14 of 16NP_000259.1
NF2
NM_001407066.1
c.1451T>Cp.Met484Thr
missense
Exon 14 of 17NP_001393995.1
NF2
NM_016418.5
c.1451T>Cp.Met484Thr
missense
Exon 14 of 17NP_057502.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF2
ENST00000338641.10
TSL:1 MANE Select
c.1451T>Cp.Met484Thr
missense
Exon 14 of 16ENSP00000344666.5
NF2
ENST00000397789.3
TSL:1
c.1451T>Cp.Met484Thr
missense
Exon 14 of 17ENSP00000380891.3
NF2
ENST00000403999.7
TSL:1
c.1451T>Cp.Met484Thr
missense
Exon 14 of 16ENSP00000384797.3

Frequencies

GnomAD3 genomes
AF:
0.000716
AC:
109
AN:
152190
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00258
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000203
AC:
51
AN:
251496
AF XY:
0.000132
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000841
AC:
123
AN:
1461740
Hom.:
1
Cov.:
32
AF XY:
0.0000633
AC XY:
46
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.00302
AC:
101
AN:
33474
American (AMR)
AF:
0.000157
AC:
7
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1111908
Other (OTH)
AF:
0.000199
AC:
12
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000762
AC:
116
AN:
152308
Hom.:
2
Cov.:
32
AF XY:
0.000725
AC XY:
54
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00274
AC:
114
AN:
41562
American (AMR)
AF:
0.000131
AC:
2
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000349
Hom.:
0
Bravo
AF:
0.000805
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000214
AC:
26
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Neurofibromatosis, type 2 (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Neurofibromatosis, type 2;C3551915:Familial meningioma (1)
-
-
1
NF2-related disorder (1)
-
-
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
21
DANN
Benign
0.89
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.094
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.081
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.58
T
MutationAssessor
Benign
0.43
N
PhyloP100
4.5
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.24
Sift
Benign
0.34
T
Sift4G
Benign
0.51
T
Polyphen
0.0
B
Vest4
0.27
MVP
0.68
MPC
0.74
ClinPred
0.030
T
GERP RS
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.078
gMVP
0.21
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141538143; hg19: chr22-30074189; API